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Actinomycetes are Gram-positive bacteria that can be part of the normal human ﬂora of the gastrointestinal,
pulmonary, and genital tract. Infections are rare, slowly progressing and most commonly affect the cervicofacial
region. Actinomyces israelii is the most frequently isolated species but a number of other species may cause
infection. We report the ﬁrst postnatally acquired case of an actinomycosis caused by A. neuii in a child. We also
provide a systematic review of all published cases of A. neuii infections. In children, there is one case report of a
premature infant with perinatally acquiredA. neuii sepsis. In adults 21 cases have currently been reported andA.
neuii infection was associated with endophthalmitis after eye surgery, foreign material-associated infection and
abscess formation in the inguinal, axillary, and mammary area. Our case highlights that a A. neuii infection is
also a potential differential diagnosis in children with chronic lymphadenitis.
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Actinomycosis is a rare infection in children younger than
10 years of age [1]. It mainly affects the cervicofacial re-
gion, but many other sites of infection have been described
[2]. Actinomycosis is usually caused by Actinomyces isra-
elii, a Gram-positive bacterium that colonizes the oral cav-
ity. With the development of molecular techniques in
recent years, it was recognized that some Actinomyces spe-
cies were misclassiﬁed (eg, as Actinobaculum species), and
a number of new Actinomyces species have been identiﬁed
[3, 4]. Atypical coryneform bacteria (initially designated as
Centers for Disease Control and Prevention [CDC] fermen-
tative coryneform group 1 [5]) were isolated for the ﬁrst
time in the 1980s from patients with endophthalmitis,
and the organism was subsequently named A. neuii in
1994 [6]. Interestingly current adult literature suggests
that A. neuii has a different spectrum of disease and most
frequently presents with skin and soft tissue infection or
abscesse. In children, there is currently only 1 published
case report of A. neuii sepsis in a premature infant born
to a mother with pelvic infection and chorioamnionitis
[7]. We report here the ﬁrst, to our knowledge, case of a
postnatally acquired A. neuii infection in a child presenting
with cervical lymphadenitis.
CASE
A 20-month-old previously healthy girl presented to our
emergency department with a 3-week history of subman-
dibular swelling. Ultrasonographic examination per-
formed 1 week before presentation showed a multilobar
calciﬁed structure measuring 1.5 cm in diameter. After a
rapid increase of the swelling within 24 hours, the child
presented to our hospital. The parents reported that since
birth, the child was known to have a small cervical sinus
tract that intermittently drained foul-smelling ﬂuid. The
child had not had any contact with sick individuals, and
her family history was unremarkable.
On physical examination, the girl was afebrile and had a
submandibular, ﬁrm, nonﬂuctuant, nontender swellingwith
a sinus tract. She also had an itching macular rash over the
cervical area. Results of the remaining examination were
normal. In particular, there were no other enlarged lymph
nodes. Her dentition was normal, and there were no lesions
in her mouth. A full blood count revealed a hemoglobin
value of 117 g/L, a white blood cell count of 13.7 × 109/L
(62%neutrophils, 31% lymphocytes, 6%monocytes, 1% eo-
sinophils), a platelet count of 491 × 109/L, and a C-reactive
protein level of 9 mg/L. Repeated ultrasonography of the
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neck conﬁrmed the multilobar structure located at the an-
terior border of the sternocleidomastoid muscle with a
diameter of 2 cm and a ﬁstula adjacent to the multilobular
structure extending to the skin.
The following day, the mass and ﬁstula were excised.
Histopathological examination revealed purulent inﬂam-
mation and small fragments of squamous epithelium
(Figure 1A and B). Sulfur granules were not identiﬁed.
A Gram stain from several deep cervical swabs showed
Gram-positive rods (Figure 2), Gram-positive cocci, and
Gram-negative pleomorphic rods. Culture resulted in poly-
microbial growth of Prevotella timonensis, viridans strep-
tococci, anaerobic Gram-positive cocci, and A. neuii.
Identiﬁcation of A. neuii was achieved from pure culture
on Columbia agar supplemented with 5% sheep blood
(BD Diagnostic Systems, Allschwil, Switzerland). The cat-
alase reaction was positive, and the Gram stain revealed
coryneform, short rods. In addition, matrix-assisted laser
desorption ionization time-of-ﬂight mass spectrometry
(MALDI-TOF MS) (Microﬂex LT, Bruker Daltonics) was
performed using a short extraction protocol with 1 µL of
70% formic acid added to the smears followed by applica-
tion of the matrix solution. Analysis of the raw spectral
data was performed with MALDI Biotyper software 3.0
(Bruker Daltonics) with reference database version
3.1.2.0 (3995 database entries) and identiﬁed A. neuii
with a score of 2.108. Identiﬁcation of P. timonensis was
done using a 16S rRNA gene sequence analysis. The anaer-
obe cocci and the viridans streptococci identiﬁed with
culture and Gram staining were not further identiﬁed to
the species level. Staining for acid-fast bacilli and
Figure 1. Hematoxylin and eosin (H&E) (A) and periodic acid–Schiff (PAS) (B) staining of histological sections of excised cervical lymph node showing purulent
inﬂammation and small fragments of squamous epithelium (×200 magniﬁcation). H&E (C) and PAS (D) staining of histological sections from the second operation
showing the remaining sinus tract lined with squamous epithelium cells adjacent to elastic cartilage (C) and follicular hyperplasia of the lymph node (D) (×10
magniﬁcation).
Figure 2. Gram stain of the A neuii isolate showing coryneform nonbranching
Gram-positive rods (×400 magniﬁcation).
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Table 1. Details of All Currently Reported Cases of Actinomyces neuii Infection Highlighting the Variance of Infection Locations and Treatment
Ref. Age Gender
Type of Infection/Underlying
Condition
Sample(s) Positive for
A neuii
Antibiotic
susceptibility Surgical Treatment
Antibiotic Treatment
(Dose per d)
Duration of
Treatment (d) Outcome
7 1 d F Sepsis/maternal
chorioamnionitis
Blood culture, culture of
gastric aspirate and
residual amniotic fluid in
external ear canal
Pen, Cefo, Vanco, Imi,
Ery
None Amp (100 mg/kg), Gent
(3 mg/kg) iv
14 Cured
Pen G (30 mg/kg) oral 28
Our case 1.6 y F Infection of lateral cervical cyst Culture of intraoperative
sample
NS Drainage with
excochleation,
secondary selective
neck dissection
Amox-Clav (180 mg/kg) iv 4 Cured
Amox-Clav (80 mg/kg) oral 178
18 28 y M Infection of pilonidal cyst Culture of purulent fluid NS None Pen V NS NS
20 39 y F Chronic pericarditis PCR of pericardial fluid NS Pericardial fluid
drainage
NS NS NS
25 46 y F Breast abscess Culture of fine-needle
aspirate
NS Surgical debridement Amox (2–3 g) oral 28 Cured
19 48 y F Breast abscess Culture of fine-needle
aspirate
NS None Amox 21 Cured
18 48 y F Breast abscess Culture of intraoperative
sample
NS Surgical debridement Pen V NS NS
12 58 y M Endophthalmitis/
phacoemulsification with
posterior chamber intraocular
lens implant
Culture of anterior chamber
and vitreous body taps
Pen, Amox/Clav, Cefa,
Cefu, Ceftr, Vanco,
Imi, Oxa, Levo
None Intravitreous: Vanco (2 mg),
Ami (400 μg)
NS Poor visual acuity (20/40),
complicated by central
vein occlusion
Peribulbar: Vanco (25 mg) NS
Ocular: Tobra NS
Cephalexin (2 g) NS
17 64 y F Mammary prosthesis infection Culture of swab from
mammary prosthesis
Ery, Pen, Tetra, Vanco Removal of mammary
prosthesis
Amox-Clav (4.4 g) Preop period Cured
Amox-Clav (2.4 g) Postop period
27 64 y F VP-shunt infection Culture of CSF Pen, Ceftr, Clinda,
Vanco
Removal of VP shunt Vanco, Cefepime, Amp,
Metro
18 Cured
Pen G (24 Mio IU) iv 42
Pen oral 180
21 66 y M Prosthetic valve endocarditis Blood culture Pen None Pen G (20 Mio IU), Metro
(2 g), Ery (4 g)
21 Cured
Pen G (20 Mio IU) iv 25
Amox (2 g) oral 330
23 67 y M Perirenal abscess Blood culture NS Drainage Amp, followed by Pen and
Cipro
37 Cured
22 68 y M Endocarditis/aortic paravalvular
abscess
Blood culture Pen, Amp, Ceftr,
Vanco, Genta
Open heart surgery Amp (9 g), Gent (24 mg),
Ceftr (2 g) iv
4 NS
Amp (9 g), Gent (24 mg) iv 5
Amp iv 21
Ceftr (2 g) iv 63
Doxycycline oral 252
28 68 y F Toe ulcer/type 2 diabetes Cultures of intraoperative
samples
Pen G, Cefa, Cefo, Ery,
Clinda, Vanco,
Teico
Surgical debridement,
amputation of toe
Metro (1500 mg), Cipro
(200 mg) iv
3 Cured
Clinda (600 mg) iv 2
Clinda (600 mg), Teico
(400 mg) iv
15
Teico (800 mg) im 10
29 69 y F Bilateral endophthalmitis/
immunosuppression not
further specified
Culture of anterior chamber
fluid
NS None Intravitreous: Vanco, Cefta 1 Limited improvement of
visual acuity in right
(6/20) and left (6/120)
eyes
Pen G (4 Mio IU) iv,
Sulf ocular
21
14 73 y M Chronic endophthalmitis/
phacoemulsification with
intraocular lens implantation
Culture of anterior chamber
fluid
Ery, Pen, Tetra, Gent,
Cefu
Pars plana vitrectomy Neomycin ocular 21 Satisfactory with visual
acuity (6/18)Levo (1 g) NS
Azit (500 mg) NS
Chloramphenicol ocular NS
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13 75 y M Chronic endophthalmitis/
cataract surgery
Culture and PCR of aqueous
and vitreous fluid
Pen, Cipro, Vanco None Intravitreous: Vanco 1 mg/
0.1 mL and Cefta 2.25
mg/0.1 mL
1 After 6 mo, no symptoms,
visual acuity (20/22)
Oflox, Cefa 600 mg/12 mL
ocular
21
Cipro (1 g) 14
24 76 y M Chronic osteomyelitis of the
calcaneum with fistulation
Culture of bone from
curettage
NS Surgical curettage Cefa (2 g) 77 Cured
30 78 y F Periprosthetic infection/total hip
arthroplasty
Culture from joint fluid,
intraoperative
periprosthetic tissue
Pen, Amp, Clinda,
Levo, Vanco, Rif
Surgery (removal of
prosthesis,
Girdlestone
arthroplasty)
Cefa (6 g), Rif (900 mg) iv
Pen G (20 Mio IU) iv
7 2 wk after reimplantation,
no signs of local
infection, no further
follow up
Antibiotic-loaded bone
cement (Vanco 2 g,
Clinda 1 g, Gent 1 g per
40 g polymethyl
methacrylate)
14
Amox (3 g) oral 28
31 79 y M Infection of IPP reservoir Culture of purulent fluid
collection around the
prosthesis tubing
Amp Surgery (removal of IPP) Vanco, Piperacillin/
Tazobactam iv Kan/Cefa,
Vanco/Genta, Baci
(wound irrigation)
Preop Cured
Antibiotic treatment with
Vanco iv, cephalexin,
Amox-Clav oral, and
Amox oral
365
23 91 y M Urosepsis/chronic nephropathy Blood culture NS None Cefu and mecillinam 9 Cured
32 NS NS 2 patients with endophthalmitis/
implantation of anterior
chamber lenses
Culture of vitreous fluid Pen, Cefu, Gent None None NS NS
Abbreviations: iv, intravenous; im, intramuscular; CSF, cerebral spinal fluid; Ami, amikacin; Amox, amoxicillin; Amp, ampicillin; Azit, azithromycin; Baci, bacitracin; Cefa, cefazolin; Cefta, ceftazidime; Ceftr, ceftriaxone;
Cefo, cefotaxime; Cefu, cefuroxime; Cipro, ciprofloxacin; Clav, clavulanate; Clinda, clindamycin; Ery, erythromycin; Gent, gentamicin; Imi, imipenem; Kan, kanamycin; Levo, levofloxacin; Metro, metronidazole; Oflox,
ofloxacin; Oxa, Oxacillin; Pen, penicillin; Pred, prednisolone; Rif, rifampicin; Sulf, sulfacetamide; Tetra, tetracycline; Teico, teicoplanin; Tobra, tobramycin; Vanco, vancomycin; NS, not stated; VP, ventriculoperitoneal; IPP,
inflatable penile prosthesis.
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Mycobacterium tuberculosis complex polymerase chain re-
action (PCR) remained negative.
Intravenous amoxicillin-clavulanate (180 mg/kg/d) was
started. When the swelling and redness subsided, antibiotic
treatment was changed to oral amoxicillin-clavulanate (80
mg/kg/d), and the patient was discharged 4 days after sur-
gery. At follow-up 2 weeks later, we noted persistent dis-
charge from the wound that continued during the
following 2 months despite local antiseptic and oral antibi-
otic treatment. A remaining sinus tract was seen, and there-
fore excision of the remaining ﬁstula and adjacent lymph
nodes was performed 3 months after the initial surgery.
Pathology examination conﬁrmed a remaining sinus tract
lined with squamous epithelium cells adjacent to elastic
cartilage (Figure 1C). The resected lymph nodewas charac-
terized by distinct follicular hyperplasia (Figure 1D). Gram
staining did not reveal any bacteria, and culture remained
negative. At the next follow-up 2 weeks after the second
surgery, the wound had healed and left a small scar
(1 cm long). Treatment with amoxicillin-clavulanate was
stopped after a total of 6 months, at which time complete
resolution of the swelling was documented.
DISCUSSION
A. neuii is a coryneform, nonbranching, aerobically grow-
ing, Gram-positive rod that was named in honor of Harold
Neu in 1994 [6].A positive catalase reaction and a positive
CAMP test result are key ﬁndings in the biochemical iden-
tiﬁcation of this species today. Although the gold-standard
method for identiﬁcation of A. neuii is 16S rRNA gene
sequencing, recent reports showed that identiﬁcation with
MALDI-TOFMS is excellent even to the species level [8,9].
Therefore, it has been suggested that for Gram-positive
rods, including those of A. neuii, a species identiﬁcation
can be accepted without 16S rRNA sequencing analysis
if the MALDI-TOF MS cutoff value is higher than 2.0 [8].
Actinomyces spp. are believed to be part of the endoge-
nous ﬂora of mucous membranes in the gastrointestinal,
pulmonary, and genital tracts [10]. Recent studies have
shown that by the age of 2 years, the oral cavity of every
child is colonized with Actinomyces spp. [11].Actinomyces
odontolyticus andActinomyces naeslundii are themost com-
monly found species [11]. In contrast, A. neuii has not been
identiﬁed thus far as part of the normal oral ﬂora in the ﬁrst
2 years of life [11].
After colonization, disruption of the mucosa leading to a
microaerophilic environment is thought to promote inva-
sive infection. In adults, a total of 21 cases of A. neuii in-
fection have been described in the literature (Table 1).
A. neuii has been reported most frequently to cause
endophthalmitis after eye surgery [12–14], abscess forma-
tion, superinfections of ulcers predominantly located in the
inguinal, axillary, and mammary areas, and foreign mate-
rial–associated infections [3,15–19]. In addition further re-
ports include 3 cases of cardiac infections [20–22], 2 cases
of A. neuii bacteremia as a result of a urinary tract infection
and a perianal abscess [23] and 1 case of chronic osteomy-
elitis [23]. Additional details of all previously reported
A. neuii infections in children and adults are summarized
in Table 1.
To our knowledge, only 1 pediatric case ofA. neuii infec-
tion (in a neonate whose infection was caused by maternal
bacteremia and subsequent chorioamnionitis) has been re-
ported [7]. Our case represents the ﬁrst, to our knowledge,
postnatally acquired A. neuii infection in a child. On the
basis of the clinical presentation and the age of the child,
infection with atypical mycobacteria was initially suspect-
ed, and excision of the enlarged lymph node was per-
formed. The results of culture and PCR remained
negative for atypical mycobacteria but showed polymicro-
bial growth, including growth of A. neuii. A. neuii is com-
monly isolated together with other bacterial species,
mainly anaerobes. We considered A. neuii to be the most
important pathogen with potential contribution of the
other isolated bacteria. The subspecies of A. neuii was
not determined. Because the child was afebrile, we did
not perform a blood culture; culture results have been
shown to be positive in up to 10% of adult patients with
A. neuii infection [6, 15]. Interestingly, histopathological
examination did not reveal any sulfur granules, which are
usually a hallmark of actinomycosis. However, the absence
of sulfur granules has been reported, particularly in
A. neuii infections [25]. On the basis of reports on adults,
antibiotic treatment with amoxicillin-clavulanate was
started. In addition, amoxicillin-clavulanic acid was also
considered to be active against the other isolated bacteria.
Antimicrobial susceptibility testing for Actinomyces spp. is
not routinely performed at our microbiology laboratory,
because internal data have shown that all Actinomyces
species are susceptible to amoxicillin-clavulanic acid.
Other potential treatment options reported in the literature
are ampicillin, penicillin, and cephalosporins [26]. On the
basis of experience with infections with other Actinomyces
spp., we opted for a 6-month antibiotic treatment course
with regular follow-ups. Three months after starting treat-
ment, persistent drainage from the lymph node was noted
to be a result of a remaining sinus tract rather than treat-
ment failure, because cultures from the second sample re-
mained sterile.
In conclusion, infection with A. neuii is a potential dif-
ferential diagnosis for children with chronic lymphadenitis
e36 Walther et al
and particularly those with presumed atypical mycobacte-
rial infection with negative mycobacterial culture and PCR
results from lymph nodes.
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